M

MCKESSON CORP

MCK NYSE Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries Irving, TX www.mckesson.com
$869.30
Mkt Cap 101.78B
Index McKESSON CORPORATION PART I Item 1. Business. INDEX TO BUSINESS Section Page General 3 Business Segments 4 North American Pharmaceutical 4 Oncology & Multispecialty 7 Prescription Technology Sol…

Index McKESSON CORPORATION PART I Item 1. Business. INDEX TO BUSINESS Section Page General 3 Business Segments 4 North American Pharmaceutical 4 Oncology & Multispecialty 7 Prescription Technology Solutions 8 Medical-Surgical Solutions 8 Investments, Restructuring, Business Combinations, and Divestitures 8 Competition 8 Patents, Trademarks, Copyrights, and Licenses 9 Human Capital 9 Government Regulation 10 Other Information about the Business 13 Forward-Looking Statements 14 General McKesson Corporation together with its subsidiaries (collectively, the Company, McKesson, we, our, or us and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in this document to a particular year refer to the Company’s fiscal year. The Company was incorporated on July 7, 1994 in the State of Delaware.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$410.98B
FCF TTM
$6.18B
P/E RATIO
22.2x
P/FCF
16.5x
Running full 6-factor analysis…